Director of Research and Development at Nephrosant, Inc - Brisbane, California, United States
Kidney transplantation is the treatment of choice for patients with end-stage kidney failure. However, the life of a kidney transplant is limited due to unrecognized immune injury. There is no sensitive, non-invasive method to detect this injury at an early-stage. We have developed a reliable, inexpensive, and noninvasive assay to monitor kidney injury.